Riordan, Lewis & Haden's sale of Avella fetches about $325 mln

17 October 2018•2 mins read
Riordan, Lewis & Haden, Avella Specialty Pharmacy, UnitedHealth Group, Drugs, medicine, pharmacy, private equity, merger, M&A,
LinkedInXEmail
LinkedInXEmail

Related articles